カテゴリー： QYResearch, 世界

世界の新規経口抗凝固剤（NOAC）市場

QYResearchが発行した調査報告書（DATA909X12113）
◆英語タイトル：Global Novel Oral AntiCoagulants (NOAC) Market Professional Survey Report 2019
◆商品コード：DATA909X12113
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月20日（※2024年版があります。お問い合わせください）
◆ページ数：110
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
※本調査レポートは、新規経口抗凝固剤（NOAC）の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、直接トロンビン阻害剤、直接因子Xa阻害剤に、用途別には、深部静脈血栓症（DVT）、肺塞栓症、急性冠症候群、血液透析、その他にセグメント区分し、新規経口抗凝固剤（NOAC）の世界市場を分析しました。


・エグゼクティブ・サマリー
・新規経口抗凝固剤（NOAC）の世界市場概要
・新規経口抗凝固剤（NOAC）の製造コスト構成分析
・新規経口抗凝固剤（NOAC）の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・新規経口抗凝固剤（NOAC）の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・新規経口抗凝固剤（NOAC）のセグメント分析（種類別）
（直接トロンビン阻害剤、直接因子Xa阻害剤）
・新規経口抗凝固剤（NOAC）のセグメント分析（用途別）
（深部静脈血栓症（DVT）、肺塞栓症、急性冠症候群、血液透析、その他）
・新規経口抗凝固剤（NOAC）の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Johnson & Johnson、Bristol-Myers Squibb、Boehringer Ingelheim、Sanofi、Daiichi Sankyo、Armatheon、Aspen、AstraZeneca、Bayer、Cellceutix、Cosmo Pharmaceuticals、CSL Behring、Eisai、GSK、Marathon Pharmaceuticals、Ockham Biotech、Perosphere、）
・新規経口抗凝固剤（NOAC）の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Novel Oral AntiCoagulants (NOAC) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Novel Oral AntiCoagulants (NOAC) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Novel Oral AntiCoagulants (NOAC) market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Novel Oral AntiCoagulants (NOAC) in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Novel Oral AntiCoagulants (NOAC) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Johnson & Johnson
Bristol-Myers Squibb
Boehringer Ingelheim
Sanofi
Daiichi Sankyo
Armatheon
Aspen
AstraZeneca
Bayer
Cellceutix
Cosmo Pharmaceuticals
CSL Behring
Eisai
GSK
Marathon Pharmaceuticals
Ockham Biotech
Perosphere

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Direct Thrombin Inhibitors
Direct Factor Xa Inhibitors

Segment by Application
Deep Vein Thrombosis (DVT)
Pulmonary Embolism
Acute Coronary Syndrome
Hemodialysis
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Novel Oral AntiCoagulants (NOAC)
1.1 Definition of Novel Oral AntiCoagulants (NOAC)
1.2 Novel Oral AntiCoagulants (NOAC) Segment by Type
1.2.1 Global Novel Oral AntiCoagulants (NOAC) Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Direct Thrombin Inhibitors
1.2.3 Direct Factor Xa Inhibitors
1.3 Novel Oral AntiCoagulants (NOAC) Segment by Applications
1.3.1 Global Novel Oral AntiCoagulants (NOAC) Consumption Comparison by Applications (2014-2025)
1.3.2 Deep Vein Thrombosis (DVT)
1.3.3 Pulmonary Embolism
1.3.4 Acute Coronary Syndrome
1.3.5 Hemodialysis
1.3.6 Others
1.4 Global Novel Oral AntiCoagulants (NOAC) Overall Market
1.4.1 Global Novel Oral AntiCoagulants (NOAC) Revenue (2014-2025)
1.4.2 Global Novel Oral AntiCoagulants (NOAC) Production (2014-2025)
1.4.3 North America Novel Oral AntiCoagulants (NOAC) Status and Prospect (2014-2025)
1.4.4 Europe Novel Oral AntiCoagulants (NOAC) Status and Prospect (2014-2025)
1.4.5 China Novel Oral AntiCoagulants (NOAC) Status and Prospect (2014-2025)
1.4.6 Japan Novel Oral AntiCoagulants (NOAC) Status and Prospect (2014-2025)
1.4.7 Southeast Asia Novel Oral AntiCoagulants (NOAC) Status and Prospect (2014-2025)
1.4.8 India Novel Oral AntiCoagulants (NOAC) Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Novel Oral AntiCoagulants (NOAC)
2.3 Manufacturing Process Analysis of Novel Oral AntiCoagulants (NOAC)
2.4 Industry Chain Structure of Novel Oral AntiCoagulants (NOAC)

3 Development and Manufacturing Plants Analysis of Novel Oral AntiCoagulants (NOAC)
3.1 Capacity and Commercial Production Date
3.2 Global Novel Oral AntiCoagulants (NOAC) Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Novel Oral AntiCoagulants (NOAC)
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Novel Oral AntiCoagulants (NOAC) Production and Capacity Analysis
4.2 Novel Oral AntiCoagulants (NOAC) Revenue Analysis
4.3 Novel Oral AntiCoagulants (NOAC) Price Analysis
4.4 Market Concentration Degree

5 Novel Oral AntiCoagulants (NOAC) Regional Market Analysis
5.1 Novel Oral AntiCoagulants (NOAC) Production by Regions
5.1.1 Global Novel Oral AntiCoagulants (NOAC) Production by Regions
5.1.2 Global Novel Oral AntiCoagulants (NOAC) Revenue by Regions
5.2 Novel Oral AntiCoagulants (NOAC) Consumption by Regions
5.3 North America Novel Oral AntiCoagulants (NOAC) Market Analysis
5.3.1 North America Novel Oral AntiCoagulants (NOAC) Production
5.3.2 North America Novel Oral AntiCoagulants (NOAC) Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Novel Oral AntiCoagulants (NOAC) Import and Export
5.4 Europe Novel Oral AntiCoagulants (NOAC) Market Analysis
5.4.1 Europe Novel Oral AntiCoagulants (NOAC) Production
5.4.2 Europe Novel Oral AntiCoagulants (NOAC) Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Novel Oral AntiCoagulants (NOAC) Import and Export
5.5 China Novel Oral AntiCoagulants (NOAC) Market Analysis
5.5.1 China Novel Oral AntiCoagulants (NOAC) Production
5.5.2 China Novel Oral AntiCoagulants (NOAC) Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Novel Oral AntiCoagulants (NOAC) Import and Export
5.6 Japan Novel Oral AntiCoagulants (NOAC) Market Analysis
5.6.1 Japan Novel Oral AntiCoagulants (NOAC) Production
5.6.2 Japan Novel Oral AntiCoagulants (NOAC) Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Novel Oral AntiCoagulants (NOAC) Import and Export
5.7 Southeast Asia Novel Oral AntiCoagulants (NOAC) Market Analysis
5.7.1 Southeast Asia Novel Oral AntiCoagulants (NOAC) Production
5.7.2 Southeast Asia Novel Oral AntiCoagulants (NOAC) Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Novel Oral AntiCoagulants (NOAC) Import and Export
5.8 India Novel Oral AntiCoagulants (NOAC) Market Analysis
5.8.1 India Novel Oral AntiCoagulants (NOAC) Production
5.8.2 India Novel Oral AntiCoagulants (NOAC) Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Novel Oral AntiCoagulants (NOAC) Import and Export

6 Novel Oral AntiCoagulants (NOAC) Segment Market Analysis (by Type)
6.1 Global Novel Oral AntiCoagulants (NOAC) Production by Type
6.2 Global Novel Oral AntiCoagulants (NOAC) Revenue by Type
6.3 Novel Oral AntiCoagulants (NOAC) Price by Type

7 Novel Oral AntiCoagulants (NOAC) Segment Market Analysis (by Application)
7.1 Global Novel Oral AntiCoagulants (NOAC) Consumption by Application
7.2 Global Novel Oral AntiCoagulants (NOAC) Consumption Market Share by Application (2014-2019)

8 Novel Oral AntiCoagulants (NOAC) Major Manufacturers Analysis
8.1 Johnson & Johnson
8.1.1 Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
8.1.2 Johnson & Johnson Product Introduction, Application and Specification
8.1.3 Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Bristol-Myers Squibb
8.2.1 Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
8.2.2 Bristol-Myers Squibb Product Introduction, Application and Specification
8.2.3 Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Boehringer Ingelheim
8.3.1 Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
8.3.2 Boehringer Ingelheim Product Introduction, Application and Specification
8.3.3 Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Sanofi
8.4.1 Sanofi Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
8.4.2 Sanofi Product Introduction, Application and Specification
8.4.3 Sanofi Novel Oral AntiCoagulants (NOAC) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Daiichi Sankyo
8.5.1 Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
8.5.2 Daiichi Sankyo Product Introduction, Application and Specification
8.5.3 Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Armatheon
8.6.1 Armatheon Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
8.6.2 Armatheon Product Introduction, Application and Specification
8.6.3 Armatheon Novel Oral AntiCoagulants (NOAC) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Aspen
8.7.1 Aspen Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
8.7.2 Aspen Product Introduction, Application and Specification
8.7.3 Aspen Novel Oral AntiCoagulants (NOAC) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 AstraZeneca
8.8.1 AstraZeneca Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
8.8.2 AstraZeneca Product Introduction, Application and Specification
8.8.3 AstraZeneca Novel Oral AntiCoagulants (NOAC) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Bayer
8.9.1 Bayer Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
8.9.2 Bayer Product Introduction, Application and Specification
8.9.3 Bayer Novel Oral AntiCoagulants (NOAC) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Cellceutix
8.10.1 Cellceutix Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
8.10.2 Cellceutix Product Introduction, Application and Specification
8.10.3 Cellceutix Novel Oral AntiCoagulants (NOAC) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Cosmo Pharmaceuticals
8.12 CSL Behring
8.13 Eisai
8.14 GSK
8.15 Marathon Pharmaceuticals
8.16 Ockham Biotech
8.17 Perosphere

9 Development Trend of Analysis of Novel Oral AntiCoagulants (NOAC) Market
9.1 Global Novel Oral AntiCoagulants (NOAC) Market Trend Analysis
9.1.1 Global Novel Oral AntiCoagulants (NOAC) Market Size (Volume and Value) Forecast 2019-2025
9.2 Novel Oral AntiCoagulants (NOAC) Regional Market Trend
9.2.1 North America Novel Oral AntiCoagulants (NOAC) Forecast 2019-2025
9.2.2 Europe Novel Oral AntiCoagulants (NOAC) Forecast 2019-2025
9.2.3 China Novel Oral AntiCoagulants (NOAC) Forecast 2019-2025
9.2.4 Japan Novel Oral AntiCoagulants (NOAC) Forecast 2019-2025
9.2.5 Southeast Asia Novel Oral AntiCoagulants (NOAC) Forecast 2019-2025
9.2.6 India Novel Oral AntiCoagulants (NOAC) Forecast 2019-2025
9.3 Novel Oral AntiCoagulants (NOAC) Market Trend (Product Type)
9.4 Novel Oral AntiCoagulants (NOAC) Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Novel Oral AntiCoagulants (NOAC) Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Novel Oral AntiCoagulants (NOAC)
Table Global Novel Oral AntiCoagulants (NOAC) Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Novel Oral AntiCoagulants (NOAC) Production Market Share by Types in 2018
Figure Direct Thrombin Inhibitors Product Picture
Figure Direct Factor Xa Inhibitors Product Picture
Table Global Novel Oral AntiCoagulants (NOAC) Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Novel Oral AntiCoagulants (NOAC) Consumption Market Share by Applications in 2018
Figure Deep Vein Thrombosis (DVT)
Figure Pulmonary Embolism
Figure Acute Coronary Syndrome
Figure Hemodialysis
Figure Others
Figure Global Novel Oral AntiCoagulants (NOAC) Revenue (Million USD) (2014-2025)
Figure Global Novel Oral AntiCoagulants (NOAC) Production (K Units) (2014-2025)
Figure North America Novel Oral AntiCoagulants (NOAC) Market Size (Million USD) (2014-2025)
Figure Europe Novel Oral AntiCoagulants (NOAC) Market Size (Million USD) (2014-2025)
Figure China Novel Oral AntiCoagulants (NOAC) Market Size (Million USD) (2014-2025)
Figure Japan Novel Oral AntiCoagulants (NOAC) Market Size (Million USD) (2014-2025)
Figure Southeast Asia Novel Oral AntiCoagulants (NOAC) Market Size (Million USD) (2014-2025)
Figure India Novel Oral AntiCoagulants (NOAC) Market Size (Million USD) (2014-2025)
Table Novel Oral AntiCoagulants (NOAC) Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Novel Oral AntiCoagulants (NOAC) in 2018
Figure Manufacturing Process Analysis of Novel Oral AntiCoagulants (NOAC)
Figure Industry Chain Structure of Novel Oral AntiCoagulants (NOAC)
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Novel Oral AntiCoagulants (NOAC) Manufacturing Plants Distribution
Table Novel Oral AntiCoagulants (NOAC) Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Novel Oral AntiCoagulants (NOAC) Capacity (K Units) of Major Manufacturers (2014-2019)
Table Novel Oral AntiCoagulants (NOAC) Production (K Units) of Major Manufacturers (2014-2019)
Table Novel Oral AntiCoagulants (NOAC) Production Market Share of Major Manufacturers (2014-2019)
Figure Novel Oral AntiCoagulants (NOAC) Production Share by Manufacturers in 2018
Table Novel Oral AntiCoagulants (NOAC) Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Novel Oral AntiCoagulants (NOAC) Revenue Market Share of Major Manufacturers (2014-2019)
Figure Novel Oral AntiCoagulants (NOAC) Revenue Share by Manufacturers in 2018
Table Novel Oral AntiCoagulants (NOAC) Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Novel Oral AntiCoagulants (NOAC) Production by Regions 2014-2019 (K Units)
Table Global Novel Oral AntiCoagulants (NOAC) Production Market Share by Regions 2014-2019
Figure Global Novel Oral AntiCoagulants (NOAC) Production Market Share by Regions in 2018
Table Global Novel Oral AntiCoagulants (NOAC) Revenue by Regions 2014-2019 (Million USD)
Table Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Regions 2014-2019
Figure Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Regions in 2018
Table Global Novel Oral AntiCoagulants (NOAC) Consumption by Regions 2014-2019 (K Units)
Table Global Novel Oral AntiCoagulants (NOAC) Consumption Market Share by Regions 2014-2019
Figure North America Novel Oral AntiCoagulants (NOAC) Production Growth Rate 2014-2019 (K Units)
Figure North America Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate 2014-2019 (Million USD)
Table North America Novel Oral AntiCoagulants (NOAC) Production, Consumption Import and Export (K Units)
Figure Europe Novel Oral AntiCoagulants (NOAC) Production Growth Rate 2014-2019 (K Units)
Figure Europe Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Novel Oral AntiCoagulants (NOAC) Production, Consumption Import and Export (K Units)
Figure China Novel Oral AntiCoagulants (NOAC) Production Growth Rate 2014-2019 (K Units)
Figure China Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate 2014-2019 (Million USD)
Table China Novel Oral AntiCoagulants (NOAC) Production, Consumption Import and Export (K Units)
Figure Japan Novel Oral AntiCoagulants (NOAC) Production Growth Rate 2014-2019 (K Units)
Figure Japan Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Novel Oral AntiCoagulants (NOAC) Production, Consumption Import and Export (K Units)
Figure Southeast Asia Novel Oral AntiCoagulants (NOAC) Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Novel Oral AntiCoagulants (NOAC) Production, Consumption Import and Export (K Units)
Figure India Novel Oral AntiCoagulants (NOAC) Production Growth Rate 2014-2019 (K Units)
Figure India Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate 2014-2019 (Million USD)
Table India Novel Oral AntiCoagulants (NOAC) Production, Consumption Import and Export (K Units)
Figure Global Consumption Novel Oral AntiCoagulants (NOAC) Market Share by Application (2014-2019)
Figure Global Value (Consumption) Novel Oral AntiCoagulants (NOAC) Market Share by Application (2014-2019)
Table Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
Table Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Production Growth Rate (2014-2019)
Table Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Production Market Share (2014-2019)
Figure Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Revenue Market Share (2014-2019)
Table Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Main Business and Markets Served
Table Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
Table Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Production Market Share (2014-2019)
Figure Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Main Business and Markets Served
Table Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
Table Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Production Growth Rate (2014-2019)
Table Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Production Market Share (2014-2019)
Figure Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Revenue Market Share (2014-2019)
Table Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Main Business and Markets Served
Table Sanofi Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table Sanofi Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
Table Sanofi Novel Oral AntiCoagulants (NOAC) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Novel Oral AntiCoagulants (NOAC) Production Growth Rate (2014-2019)
Table Sanofi Novel Oral AntiCoagulants (NOAC) Production Market Share (2014-2019)
Figure Sanofi Novel Oral AntiCoagulants (NOAC) Revenue Market Share (2014-2019)
Table Sanofi Novel Oral AntiCoagulants (NOAC) Main Business and Markets Served
Table Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
Table Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Production Growth Rate (2014-2019)
Table Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Production Market Share (2014-2019)
Figure Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Revenue Market Share (2014-2019)
Table Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Main Business and Markets Served
Table Armatheon Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table Armatheon Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
Table Armatheon Novel Oral AntiCoagulants (NOAC) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Armatheon Novel Oral AntiCoagulants (NOAC) Production Growth Rate (2014-2019)
Table Armatheon Novel Oral AntiCoagulants (NOAC) Production Market Share (2014-2019)
Figure Armatheon Novel Oral AntiCoagulants (NOAC) Revenue Market Share (2014-2019)
Table Armatheon Novel Oral AntiCoagulants (NOAC) Main Business and Markets Served
Table Aspen Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table Aspen Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
Table Aspen Novel Oral AntiCoagulants (NOAC) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Aspen Novel Oral AntiCoagulants (NOAC) Production Growth Rate (2014-2019)
Table Aspen Novel Oral AntiCoagulants (NOAC) Production Market Share (2014-2019)
Figure Aspen Novel Oral AntiCoagulants (NOAC) Revenue Market Share (2014-2019)
Table Aspen Novel Oral AntiCoagulants (NOAC) Main Business and Markets Served
Table AstraZeneca Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table AstraZeneca Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
Table AstraZeneca Novel Oral AntiCoagulants (NOAC) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Novel Oral AntiCoagulants (NOAC) Production Growth Rate (2014-2019)
Table AstraZeneca Novel Oral AntiCoagulants (NOAC) Production Market Share (2014-2019)
Figure AstraZeneca Novel Oral AntiCoagulants (NOAC) Revenue Market Share (2014-2019)
Table AstraZeneca Novel Oral AntiCoagulants (NOAC) Main Business and Markets Served
Table Bayer Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table Bayer Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
Table Bayer Novel Oral AntiCoagulants (NOAC) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer Novel Oral AntiCoagulants (NOAC) Production Growth Rate (2014-2019)
Table Bayer Novel Oral AntiCoagulants (NOAC) Production Market Share (2014-2019)
Figure Bayer Novel Oral AntiCoagulants (NOAC) Revenue Market Share (2014-2019)
Table Bayer Novel Oral AntiCoagulants (NOAC) Main Business and Markets Served
Table Cellceutix Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table Cellceutix Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
Table Cellceutix Novel Oral AntiCoagulants (NOAC) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Cellceutix Novel Oral AntiCoagulants (NOAC) Production Growth Rate (2014-2019)
Table Cellceutix Novel Oral AntiCoagulants (NOAC) Production Market Share (2014-2019)
Figure Cellceutix Novel Oral AntiCoagulants (NOAC) Revenue Market Share (2014-2019)
Table Cellceutix Novel Oral AntiCoagulants (NOAC) Main Business and Markets Served
Table Cosmo Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table CSL Behring Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table Eisai Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table GSK Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table Marathon Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table Ockham Biotech Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table Perosphere Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Figure Global Novel Oral AntiCoagulants (NOAC) Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Novel Oral AntiCoagulants (NOAC) Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Novel Oral AntiCoagulants (NOAC) Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Novel Oral AntiCoagulants (NOAC) Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Novel Oral AntiCoagulants (NOAC) Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Novel Oral AntiCoagulants (NOAC) Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Novel Oral AntiCoagulants (NOAC) Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Novel Oral AntiCoagulants (NOAC) Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Novel Oral AntiCoagulants (NOAC) Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Novel Oral AntiCoagulants (NOAC) by Type (2019-2025)
Table Global Consumption (K Units) of Novel Oral AntiCoagulants (NOAC) by Application (2019-2025)
Table Novel Oral AntiCoagulants (NOAC) Distributors List
Table Novel Oral AntiCoagulants (NOAC) Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Johnson & Johnson、Bristol-Myers Squibb、Boehringer Ingelheim、Sanofi、Daiichi Sankyo、Armatheon、Aspen、AstraZeneca、Bayer、Cellceutix、Cosmo Pharmaceuticals、CSL Behring、Eisai、GSK、Marathon Pharmaceuticals、Ockham Biotech、Perosphere、

【免責事項】
https://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の新規経口抗凝固剤（NOAC）市場(Global Novel Oral AntiCoagulants (NOAC) Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 鼻ポリープ薬の世界市場：規模・現状・予測
  • 世界の電池用ニッケルメッキ鋼板産業：成長傾向・競合分析
  • 世界のグローブコンパートメント産業：成長傾向・競合分析
  • 世界のツインパウチ包装市場
  • 世界のタービン流量センサー市場
  • 世界のスリミングデバイス市場
  • 世界のプレミックス薬用飼料添加物市場
  • 世界の非負圧周波数給水装置市場
  • 世界のレーザーセンサー市場
  • 世界のジャイレイトリークラッシャー市場
  • 世界のグローライト市場
  • 世界の電気ブロードライヤー市場
  • 世界のEEGヘッドセット市場
  • 世界の頭部保護具市場
  • 世界のアニールガラス市場